Today’s enterprises store valuable business intelligence in documents, including Word files, PDFs, spreadsheets, and physical records. By extracting valuable insights from documents, enterprise ...

C-Suite executives are being warned that a previously undocumented Microsoft attack platform, codename Venom, can neutralize ...

IDAHO FALLS, Idaho--(BUSINESS WIRE)--Antares, a nuclear fission energy company developing microreactors for defense and space applications, today announced that the U.S. Department of Energy (DOE) has ...

Eli Lilly’s once-daily pill for weight loss got approval from U.S. drug regulators Wednesday. The all-clear sets up a battle with rival Novo Nordisk, which has been selling a pill version of its ...

President Trump said Wednesday at the National Republican Congressional Committee’s (NRCC) annual fundraising dinner that he avoids using the word “war” to describe the conflict in Iran. “I won’t use ...

Senate staff have been approved to use three major AI chatbots for official work. That includes OpenAI's ChatGPT, Google Gemini, and Microsoft Copilot. Lawmakers and staffers have already been ...

Recent polls show more voters disapprove of President Trump's handling of the war in Iran than approve. Trump's overall job approval rating remains underwater, according to several recent polls and ...

Nearly six months ago, federal health officials gathered at the White House with President Donald Trump and vowed to “go bold” on autism. They sketched out plans for what they described as an ...

The city’s first restaurant with an onsite beer-brewing operation, or at least the first full-scale one in decades, won permit approval from the Encinitas Planning Commission Thursday. Commissioners ...

President Trump speaks during an event about the Ratepayer Protection Pledge, in the Indian Treaty Room of the Eisenhower Executive Office Building on the White House complex, on March 4, 2026, in ...

A Boehringer Ingelheim drug now has FDA approval as an earlier treatment for lung cancers expressing a certain genetic signature, a regulatory decision handed out under the agency’s new pilot program ...

Four years after the FDA issued its most heavy-handed form of a rejection to the prior company behind pegzilarginase, the U.S. regulator has now given the treatment a thumbs-up. Scoring the ...